GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

DaVita DVA · USD

Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States

S&P 500

Compare

185.54

-3.04%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$13.64bn

FY2016FY2025

Net income

$746.8m

FY2016FY2025

Free cash flow

$1.31bn

FY2016FY2025

Shareholders' equity

$1.16bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$13.64bn$12.82bn$12.14bn$11.61bn$11.62bn$11.55bn$11.39bn$11.40bn$10.88bn$14.75bn
Gross profit$3.68bn$4.22bn$3.82bn$3.40bn$3.65bn$3.56bn$3.47bn$3.21bn$3.24bn$3.28bn
Operating income$2.01bn$2.09bn$1.60bn$1.32bn$1.80bn$1.69bn$1.64bn$1.53bn$1.81bn$2.03bn
Net income$746.8m$936.3m$691.5m$560.4m$978.5m$773.6m$811.0m$159.4m$663.6m$879.9m
Diluted earnings per share8.4810.917.456.109.336.676.210.963.594.47

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$17.48bn$17.29bn$16.89bn$16.93bn$17.12bn$16.99bn$17.31bn$19.11bn$18.95bn$18.74bn
Cash and short-term investments$782.0m$846.0m$391.7m$321.8m$484.2m$345.1m$1.11bn$326.0m$551.8m$1.22bn
Total liabilities$16.32bn$15.19bn$14.15bn$14.70bn$14.75bn$14.09bn$13.81bn$14.08bn$13.05bn$12.92bn
Debt$10.27bn$9.45bn$8.39bn$8.92bn$8.91bn$8.09bn$8.11bn$10.10bn$9.34bn$9.11bn
Shareholders' equity$1.16bn$2.09bn$2.74bn$2.22bn$2.37bn$2.90bn$3.50bn$5.03bn$5.90bn$5.82bn
Shares outstanding88m86m93m92m105m116m131m166m185m197m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.89bn$2.02bn$2.06bn$1.56bn$1.93bn$1.98bn$2.07bn$1.77bn$1.91bn$1.96bn
Capital spending−$575.9m−$555.4m−$568.0m−$603.4m−$641.5m−$674.5m−$766.5m−$987.1m−$905.3m−$829.1m
Free cash flow$1.31bn$1.47bn$1.49bn$961.1m$1.29bn$1.30bn$1.31bn$784.5m$1.00bn$1.13bn
Dividends paid———−$267.9m−$244.0m−$253.1m−$11.4m−$196.4m−$211.5m−$192.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$3.55bn$3.42bn$3.62bn$3.42bn$3.38bn$3.22bn$3.29bn$3.26bn
Gross profit$1.16bn$1.07bn$1.02bn$1.09bn$1.12bn$983.9m$1.07bn$1.11bn
Operating income$570.8m$481.9m$551.2m$505.8m$537.8m$438.9m$565.4m$534.9m
Net income$265.4m$197.5m$234.2m$150.3m$199.3m$162.9m$259.3m$214.7m
Diluted earnings per share4.022.992.661.712.261.853.022.50
Cash from operations$490.0m$320.0m$540.0m$841.0m$324.0m$180.0m$547.0m$810.0m
Capital spending−$169.0m−$102.0m−$145.0m−$166.0m−$121.0m−$143.0m−$170.0m−$139.0m
Free cash flow$321.0m$218.0m$395.0m$675.0m$203.0m$37.0m$377.0m$671.0m
Total assets$17.71bn$17.50bn$17.48bn$17.74bn$17.49bn$17.12bn$17.29bn$17.50bn
Cash and short-term investments$688.9m$748.7m$782.0m$736.5m$739.4m$511.9m$846.0m$1.09bn
Debt$10.78bn$11.06bn$12.87bn$12.78bn$12.82bn$12.32bn$12.07bn$12.20bn
Shareholders' equity−$765.1m−$755.5m$1.16bn$1.53bn$1.55bn$1.66bn$2.09bn$2.22bn

Financial ratios

Data as of 6 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin27.0%32.9%31.5%29.3%31.4%30.8%
Operating margin14.1%15.6%13.0%11.4%15.5%14.0%
Net margin5.5%7.3%5.7%4.8%8.4%6.7%
Return on equity64.5%44.8%25.2%25.2%41.3%26.7%
Return on assets4.3%5.4%4.1%3.3%5.7%4.6%
Free cash flow yield15.6%16.8%15.8%13.2%13.7%12.8%
Revenue growth6.5%5.6%4.6%-0.1%0.6%1.4%
Earnings growth-20.2%35.4%23.4%-42.7%26.5%-4.6%
Current ratio1.29x1.26x1.19x1.20x1.32x1.27x
Debt to equity9.24x4.71x3.20x4.19x3.92x2.92x
Equity ratio6.6%12.1%16.2%13.1%13.8%17.1%
Interest coverage3.51x4.25x3.95x3.71x6.32x5.33x
Buybacks as a share of market value-2.7%7.5%-0.9%12.3%9.6%11.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.5%3.4%-0.1%
Operating income15.0%3.5%5.9%
Net income10.0%-0.7%10.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.9%30.1%30.4%28.5%
Operating margin15.5%14.0%14.3%13.8%
Net margin6.4%5.8%6.4%5.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.413.714.112.312.217.612.153.820.114.4
Price to sales0.71.00.80.61.01.20.90.81.20.9

Market value over time

30 Nov 2016 to 5 Oct 2026, in USD

$13.11bn$11.81bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-21%38%47%-32%-8%57%44%-29%11%-6%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 9 Sept 2013
  • 3-for-2 split · 16 Jun 2004
  • 5-for-3 split · 21 Oct 1997

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.